1-amino-1,3-dicarboxycyclopentane has been researched along with Hypercalcemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beka, TI; Boas, DA; Chen, J; Cheng, Q; Cui, J; Dale, AM; Devor, A; Einevoll, GT; Gratiy, SL; MacDonald, CL; Masliah, E; Nizar, K; Reznichenko, L; Saisan, PA; Sakadzić, S; Silva, GA; Sridhar, VB; Steed, TC; Tian, P; Uhlirova, H; Weldy, KL | 1 |
1 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and Hypercalcemia
Article | Year |
---|---|
In vivo stimulus-induced vasodilation occurs without IP3 receptor activation and may precede astrocytic calcium increase.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Astrocytes; Calcium; Cycloleucine; Dextrans; Egtazic Acid; Electric Stimulation; Female; Fluorescein-5-isothiocyanate; Hypercalcemia; Inositol 1,4,5-Trisphosphate Receptors; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Neurons; Neuroprotective Agents; Signal Transduction; Time Factors; Vasodilation | 2013 |